Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview.

Literature DB >> 33864823

High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview.

Jimm Grimm¹, Lawrence B Marks², Andrew Jackson³, Brian D Kavanagh⁴, Jinyu Xue⁵, Ellen Yorke³.

Abstract

Entities: Chemical

Mesh：

Year: 2021 PMID： 33864823 PMCID： PMC9447432 DOI： 10.1016/j.ijrobp.2020.10.039

Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN： 0360-3016 Impact factor: 8.013

× No keyword cloud information.

37 in total

1. Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation.

Authors: Jennifer Pursley; Issam El Naqa; Nina N Sanford; Bridget Noe; Jennifer Y Wo; Christine E Eyler; Matthew Hwang; Kristy K Brock; Beow Y Yeap; John A Wolfgang; Theodore S Hong; Clemens Grassberger
Journal: Int J Radiat Oncol Biol Phys Date: 2020-04-27 Impact factor: 7.038

Review 2. Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients.

Authors: L S Constine; C M Ronckers; C-H Hua; A Olch; L C M Kremer; A Jackson; S M Bentzen
Journal: Clin Oncol (R Coll Radiol) Date: 2019-01-19 Impact factor: 4.126

3. Reality Check.

Authors: Lawrence B Marks
Journal: Int J Radiat Oncol Biol Phys Date: 2016-07-01 Impact factor: 7.038

Review 4. Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models.

Authors: Feng Liu; An Tai; Percy Lee; Tithi Biswas; George X Ding; Isaam El Naqa; Jimm Grimm; Andrew Jackson; Feng-Ming Spring Kong; Tamara LaCouture; Billy Loo; Moyed Miften; Timothy Solberg; X Allen Li
Journal: Radiother Oncol Date: 2016-11-18 Impact factor: 6.280

5. Curing Metastatic Disease with Radiation Therapy: Myth or Reality?-Arguing for Reality.

Authors: Asal Rahimi; Robert Timmerman
Journal: Int J Radiat Oncol Biol Phys Date: 2020-07-01 Impact factor: 7.038

6. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).

Authors: Traves Crabtree; Varun Puri; Robert Timmerman; Hiran Fernando; Jeffrey Bradley; Paul A Decker; Rebecca Paulus; Joe B Putnum; Damian E Dupuy; Bryan Meyers
Journal: J Thorac Cardiovasc Surg Date: 2012-11-20 Impact factor: 5.209

7. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).

Authors: Gregory M M Videtic; Chen Hu; Anurag K Singh; Joe Y Chang; William Parker; Kenneth R Olivier; Steven E Schild; Ritsuko Komaki; James J Urbanic; Robert D Timmerman; Hak Choy
Journal: Int J Radiat Oncol Biol Phys Date: 2015-07-17 Impact factor: 7.038

8. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.

Authors: Matthew H G Katz; Fang-Shu Ou; Joseph M Herman; Syed A Ahmad; Brian Wolpin; Robert Marsh; Spencer Behr; Qian Shi; Michael Chuong; Lawrence H Schwartz; Wendy Frankel; Eric Collisson; Eugene J Koay; JoLeen M Hubbard; James L Leenstra; Jeffrey Meyerhardt; Eileen O'Reilly
Journal: BMC Cancer Date: 2017-07-27 Impact factor: 4.430

Review 9. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.

Authors: Michael T Milano; Jimm Grimm; Andrzej Niemierko; Scott G Soltys; Vitali Moiseenko; Kristin J Redmond; Ellen Yorke; Arjun Sahgal; Jinyu Xue; Anand Mahadevan; Alexander Muacevic; Lawrence B Marks; Lawrence R Kleinberg
Journal: Int J Radiat Oncol Biol Phys Date: 2020-09-11 Impact factor: 8.013

10. ASTRO Journals' Data Sharing Policy and Recommended Best Practices.

Authors: Dawit Tegbaru; Lisa Braverman; Anthony L Zietman; Sue S Yom; W Robert Lee; Robert C Miller; Isabel L Jackson; Todd McNutt; Andre Dekker
Journal: Adv Radiat Oncol Date: 2019-08-22

6 in total

1. HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR).

Authors: Chang W Song; Hyunkyung Kim; Haeun Cho; Mi-Sook Kim; Sun-Ha Paek; Heon-Joo Park; Robert J Griffin; Stephanie Terezakis; Lawrence Chinsoo Cho
Journal: Cancers (Basel) Date: 2022-07-04 Impact factor: 6.575

2. Simultaneous dose and dose rate optimization (SDDRO) of the FLASH effect for pencil-beam-scanning proton therapy.

Authors: Hao Gao; Jiulong Liu; Yuting Lin; Gregory N Gan; Guillem Pratx; Fen Wang; Katja Langen; Jeffrey D Bradley; Ronny L Rotondo; Harold H Li; Ronald C Chen
Journal: Med Phys Date: 2021-12-07 Impact factor: 4.506

3. Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for Glioblastoma.

Authors: Gustavo R Sarria; Zuzanna Smalec; Thomas Muedder; Jasmin A Holz; Davide Scafa; David Koch; Stephan Garbe; Matthias Schneider; Motaz Hamed; Hartmut Vatter; Ulrich Herrlinger; Frank A Giordano; Leonard Christopher Schmeel
Journal: Front Oncol Date: 2021-10-28 Impact factor: 6.244